Serum periostin levels serve as a biomarker for both eosinophilic airway inflammation and fixed airflow limitation in well-controlled asthmatics

Serum periostin in obstructive airways disease

(2016) James Fingleton et al.   EUROPEAN RESPIRATORY JOURNAL

Serum periostin is associated with type 2 immunity in severe asthma

(2016) Mats W. Johansson et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Using Periostin as a Biomarker in the Treatment of Asthma

(2016) Kenji Izuhara et al.   Allergy Asthma & Immunology Research

Periostin levels and eosinophilic inflammation in poorly-controlled asthma

(2016) Jodie L. Simpson et al.   BMC Pulmonary Medicine

Sputum periostin in patients with different severe asthma phenotypes

(2015) I. Bobolea et al.   ALLERGY

Full blood count parameters for the detection of asthma inflammatory phenotypes

(2014) X.-Y. Zhang et al.   CLINICAL AND EXPERIMENTAL ALLERGY

External validation of blood eosinophils, FENOand serum periostin as surrogates for sputum eosinophils in asthma

(2014) A H Wagener et al.   THORAX

Japanese Guideline for Adult Asthma 2014

(2014) Ken Ohta et al.   ALLERGOLOGY INTERNATIONAL

Increased periostin associates with greater airflow limitation in patients receiving inhaled corticosteroids

(2013) Yoshihiro Kanemitsu et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Distribution of sputum cellular phenotype in a large asthma cohort: predicting factors for eosinophilic vs neutrophilic inflammation

(2013) Florence N Schleich et al.   BMC Pulmonary Medicine

Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients

(2012) Guiquan Jia et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Periostin promotes chronic allergic inflammation in response to Th2 cytokines

(2012) Miho Masuoka et al.   JOURNAL OF CLINICAL INVESTIGATION

Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial

(2012) Ian D Pavord et al.   LANCET

Asthma phenotypes: the evolution from clinical to molecular approaches

(2012) Sally E Wenzel   NATURE MEDICINE

An Official ATS Clinical Practice Guideline: Interpretation of Exhaled Nitric Oxide Levels (FeNO) for Clinical Applications

(2011) Raed A. Dweik et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

A protective role for periostin and TGF-β in IgE-mediated allergy and airway hyperresponsiveness

(2011) E. D. Gordon et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Lebrikizumab Treatment in Adults with Asthma

(2011) Jonathan Corren et al.   NEW ENGLAND JOURNAL OF MEDICINE

Periostin, a matrix protein, is a novel biomarker for idiopathic interstitial pneumonias

(2010) M. Okamoto et al.   EUROPEAN RESPIRATORY JOURNAL

Roles of epithelial cell-derived periostin in TGF-  activation, collagen production, and collagen gel elasticity in asthma

(2010) S. S. Sidhu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

T-helper Type 2–driven Inflammation Defines Major Subphenotypes of Asthma

(2009) Prescott G. Woodruff et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Cluster Analysis and Clinical Asthma Phenotypes

(2008) Pranab Haldar et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Pathogenesis of Asthma

(2008) STEPHEN T. HOLGATE   CLINICAL AND EXPERIMENTAL ALLERGY

IL-13 induced increases in nitrite levels are primarily driven by increases in inducible nitric oxide synthase as compared with effects on arginases in human primary bronchial epithelial cells

(2008) K. Chibana et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Increased sputum and bronchial biopsy IL-13 expression in severe asthma

(2008) Shironjit K. Saha et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY